🔗 Share this article Social Media Content Creators Driving Unofficial Trade for Unapproved Slimming Drug A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations. Investigational Treatment Gaining Traction Via Social Media Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts directly for source information, while also obtaining discount codes. Active Commerce on Messaging Platforms Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors market the drug there before directing buyers to WhatsApp for transactions. Learning About Retatrutide Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic. Healthcare Experts Voice Concerns Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin. Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro. Regulatory Position and Implementation Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment. Service Response and Content Elimination According to TikTok, the service has taken down violative material and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies. Online Trading Activities Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence. After moments of entering one community, a seller posted contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, health issues or past usage. Item Details and Pricing Inside these groups, messages show dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”. Service Moderation and Safety Actions A spokesperson for Telegram said it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U. A medical professional of an online medical service connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said. Her team has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.” Manufacturer Statement A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.